GLP-1 winners and losers
GLP-1 drugs are gaining traction across Asia as Chinese developers advance candidates and Indian generics slash prices, reshaping prospects…
Blog
Everything we have picked from this writer, newest first.
GLP-1 drugs are gaining traction across Asia as Chinese developers advance candidates and Indian generics slash prices, reshaping prospects…
Trip.com dominates China’s online travel market with over 50% share and has grown international platform traffic from 1 million monthly…
Roderick van Zuylen discusses Night Watch’s value strategy, catalyst-driven screening and positions in Asian equities including Dream…